- Main
Genetic and epigenetic fine mapping of causal autoimmune disease variants
- Farh, Kyle Kai-How;
- Marson, Alexander;
- Zhu, Jiang;
- Kleinewietfeld, Markus;
- Housley, William J;
- Beik, Samantha;
- Shoresh, Noam;
- Whitton, Holly;
- Ryan, Russell JH;
- Shishkin, Alexander A;
- Hatan, Meital;
- Carrasco-Alfonso, Marlene J;
- Mayer, Dita;
- Luckey, C John;
- Patsopoulos, Nikolaos A;
- De Jager, Philip L;
- Kuchroo, Vijay K;
- Epstein, Charles B;
- Daly, Mark J;
- Hafler, David A;
- Bernstein, Bradley E
- et al.
Published Web Location
https://doi.org/10.1038/nature13835Abstract
Genome-wide association studies have identified loci underlying human diseases, but the causal nucleotide changes and mechanisms remain largely unknown. Here we developed a fine-mapping algorithm to identify candidate causal variants for 21 autoimmune diseases from genotyping data. We integrated these predictions with transcription and cis-regulatory element annotations, derived by mapping RNA and chromatin in primary immune cells, including resting and stimulated CD4(+) T-cell subsets, regulatory T cells, CD8(+) T cells, B cells, and monocytes. We find that ∼90% of causal variants are non-coding, with ∼60% mapping to immune-cell enhancers, many of which gain histone acetylation and transcribe enhancer-associated RNA upon immune stimulation. Causal variants tend to occur near binding sites for master regulators of immune differentiation and stimulus-dependent gene activation, but only 10-20% directly alter recognizable transcription factor binding motifs. Rather, most non-coding risk variants, including those that alter gene expression, affect non-canonical sequence determinants not well-explained by current gene regulatory models.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-